Subclinical Atrial Fibrillation in Older Patients

doi:10.1161/CIRCULATIONAHA.117.028845

. 2017 Oct 3;136(14):1276-1283.

doi: 10.1161/CIRCULATIONAHA.117.028845. Epub 2017 Aug 4.

Subclinical Atrial Fibrillation in Older Patients

Jeff S Healey¹, Marco Alings², Andrew Ha², Peter Leong-Sit², David H Birnie², Jacob J de Graaf², Michel Freericks², Atul Verma², Jia Wang², Darryl Leong², Hisham Dokainish², Francois Philippon², Walid Barake², William F McIntyre², Kim Simek², Michael D Hill², Shamir R Mehta², Mark Carlson², Frank Smeele², A Shekhar Pandey², Stuart J Connolly²; ASSERT-II Investigators

Affiliations

¹ From Population Health Research Institute, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., K.S., S.R.M., S.J.C.); McMaster University, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., W.F.M., S.R.M., A.S.P., S.J.C.); Amphia Ziekenhuis, Breda, the Netherlands (M.A.); WCN-Dutch Network for Cardiovascular Research (M.A.); University of Toronto, ON, Canada (A.H., A.V.); University of Western Ontario, London, Canada (P.L.-S.); University of Ottawa Heart Institute, ON, Canada (D.H.B.); Nij Smellinghe Hospital, Drachten, the Netherlands (J.J.d.G.); Ikazia Ziekenhuis, Rotterdam, the Netherlands (M.F.); Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada (F.P.); University of Alberta, Edmonton, Canada (W.B.); University of Calgary, AB, Canada (M.D.H.); St. Jude Medical, Sylmar, CA (M.C.); Slingeland Ziekenhuis, Doetinchem, the Netherlands (F.S.); and Cambridge Cardiac Care Centre, ON, Canada (A.S.P.). Jeff.Healey@phri.ca.
² From Population Health Research Institute, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., K.S., S.R.M., S.J.C.); McMaster University, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., W.F.M., S.R.M., A.S.P., S.J.C.); Amphia Ziekenhuis, Breda, the Netherlands (M.A.); WCN-Dutch Network for Cardiovascular Research (M.A.); University of Toronto, ON, Canada (A.H., A.V.); University of Western Ontario, London, Canada (P.L.-S.); University of Ottawa Heart Institute, ON, Canada (D.H.B.); Nij Smellinghe Hospital, Drachten, the Netherlands (J.J.d.G.); Ikazia Ziekenhuis, Rotterdam, the Netherlands (M.F.); Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada (F.P.); University of Alberta, Edmonton, Canada (W.B.); University of Calgary, AB, Canada (M.D.H.); St. Jude Medical, Sylmar, CA (M.C.); Slingeland Ziekenhuis, Doetinchem, the Netherlands (F.S.); and Cambridge Cardiac Care Centre, ON, Canada (A.S.P.).

PMID: 28778946
DOI: 10.1161/CIRCULATIONAHA.117.028845

Subclinical Atrial Fibrillation in Older Patients

Jeff S Healey et al. Circulation. 2017.

. 2017 Oct 3;136(14):1276-1283.

doi: 10.1161/CIRCULATIONAHA.117.028845. Epub 2017 Aug 4.

Authors

Affiliations

¹ From Population Health Research Institute, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., K.S., S.R.M., S.J.C.); McMaster University, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., W.F.M., S.R.M., A.S.P., S.J.C.); Amphia Ziekenhuis, Breda, the Netherlands (M.A.); WCN-Dutch Network for Cardiovascular Research (M.A.); University of Toronto, ON, Canada (A.H., A.V.); University of Western Ontario, London, Canada (P.L.-S.); University of Ottawa Heart Institute, ON, Canada (D.H.B.); Nij Smellinghe Hospital, Drachten, the Netherlands (J.J.d.G.); Ikazia Ziekenhuis, Rotterdam, the Netherlands (M.F.); Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada (F.P.); University of Alberta, Edmonton, Canada (W.B.); University of Calgary, AB, Canada (M.D.H.); St. Jude Medical, Sylmar, CA (M.C.); Slingeland Ziekenhuis, Doetinchem, the Netherlands (F.S.); and Cambridge Cardiac Care Centre, ON, Canada (A.S.P.). Jeff.Healey@phri.ca.
² From Population Health Research Institute, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., K.S., S.R.M., S.J.C.); McMaster University, Hamilton, ON, Canada (J.S.H., J.W., D.L., H.D., W.F.M., S.R.M., A.S.P., S.J.C.); Amphia Ziekenhuis, Breda, the Netherlands (M.A.); WCN-Dutch Network for Cardiovascular Research (M.A.); University of Toronto, ON, Canada (A.H., A.V.); University of Western Ontario, London, Canada (P.L.-S.); University of Ottawa Heart Institute, ON, Canada (D.H.B.); Nij Smellinghe Hospital, Drachten, the Netherlands (J.J.d.G.); Ikazia Ziekenhuis, Rotterdam, the Netherlands (M.F.); Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada (F.P.); University of Alberta, Edmonton, Canada (W.B.); University of Calgary, AB, Canada (M.D.H.); St. Jude Medical, Sylmar, CA (M.C.); Slingeland Ziekenhuis, Doetinchem, the Netherlands (F.S.); and Cambridge Cardiac Care Centre, ON, Canada (A.S.P.).

PMID: 28778946
DOI: 10.1161/CIRCULATIONAHA.117.028845

Abstract

Background: Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and patients with cryptogenic stroke. Whether SCAF is also common in other patients without these conditions is unknown.

Methods: We implanted subcutaneous electrocardiographic monitors (St. Jude CONFIRM-AF) in patients ≥65 years of age attending cardiovascular or neurology outpatient clinics if they had no history of atrial fibrillation but had any of the following: CHA₂DS₂-VASc score of ≥2, sleep apnea, or body mass index >30 kg/m². Eligibility also required either left atrial enlargement (≥4.4 cm or volume ≥58 mL) or increased (≥290 pg/mL) serum NT-proBNP (N-terminal pro-B-type natriuretic peptide). Patients were monitored for SCAF lasting ≥5 minutes.

Results: Two hundred fifty-six patients were followed up for 16.3±3.8 months. Baseline age was 74±6 years; mean CHA₂DS₂-VASc score was 4.1±1.4; left atrial diameter averaged 4.7±0.8 cm; and 48% had a prior stroke, transient ischemic attack, or systemic embolism. SCAF ≥5 minutes was detected in 90 patients (detection rate, 34.4%/y; 95% confidence interval [CI], 27.7-42.3). Baseline predictors of SCAF were increased age (hazard ratio [HR] per decade, 1.55; 95% CI, 1.11-2.15), left atrial dimension (HR per centimeter diameter, 1.43; 95% CI, 1.09-1.86), and blood pressure (HR per 10 mm Hg, 0.87; 95% CI, 0.78-0.98), but not prior stroke. The rate of occurrence of SCAF in those with a history of stroke, systemic embolism, or transient ischemic attack was 39.4%/y versus 30.3%/y without (P=0.32). The cumulative SCAF detection rate was higher (51.9%/y) in those with left atrial volume above the median value of 73.5 mL.

Conclusions: SCAF is frequently detected by continuous electrocardiographic monitoring in older patients without a history of atrial fibrillation who are attending outpatient cardiology and neurology clinics. Its clinical significance is unclear.

Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01694394.

Keywords: atrial fibrillation; monitoring, physiologic; stroke.

PubMed Disclaimer

Comment in

Seek and Ye Shall Find Subclinical Atrial Fibrillation in High-Risk Elderly Patients.
Wijesurendra RS, Casadei B. Wijesurendra RS, et al. Circulation. 2017 Oct 3;136(14):1284-1287. doi: 10.1161/CIRCULATIONAHA.117.029397. Circulation. 2017. PMID: 28972061 No abstract available.

Cited by

The incidence of atrial fibrillation detected by implantable loop recorders: a comparison between patients with and without embolic stroke of undetermined source.
Chousou PA, Chattopadhyay RK, Matthews G, Clark A, Vassiliou VS, Pugh PJ. Chousou PA, et al. Eur Heart J Open. 2024 Sep 1;4(5):oeae061. doi: 10.1093/ehjopen/oeae061. eCollection 2024 Sep. Eur Heart J Open. 2024. PMID: 39219854 Free PMC article.
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit.
McIntyre WF, Benz AP, Tojaga N, Brandes A, Lopes RD, Healey JS. McIntyre WF, et al. Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv4-iv11. doi: 10.1093/eurheartjsupp/suae075. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099575 Free PMC article.
Screening for atrial fibrillation: the role of CHA₂DS₂-VASc and atrial fibrillation burden.
Xing LY, Vad OB, Engler D, Svendsen JH, Diederichsen SZ. Xing LY, et al. Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv41-iv49. doi: 10.1093/eurheartjsupp/suae078. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099574 Free PMC article.
Atrial fibrillation burden: a new outcome predictor and therapeutic target.
Becher N, Metzner A, Toennis T, Kirchhof P, Schnabel RB. Becher N, et al. Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373. Eur Heart J. 2024. PMID: 38953776 Free PMC article. Review.
Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.
Sanders P, Svennberg E, Diederichsen SZ, Crijns HJGM, Lambiase PD, Boriani G, Van Gelder IC. Sanders P, et al. Eur Heart J. 2024 Aug 3;45(29):2594-2603. doi: 10.1093/eurheartj/ehae365. Eur Heart J. 2024. PMID: 38935554 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Subclinical Atrial Fibrillation in Older Patients

Affiliations

Subclinical Atrial Fibrillation in Older Patients

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials

Abstract

Comment in

Similar articles

Cited by

MeSH terms

Associated data

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials